Catalyst Pharmaceutical (CPRX)

• Market cap: $2.44B
• 1 day: -1.38%
• 5 days: -1.48%
• 1 month: -1.82%
• 3 months: -17.79%
• 6 months: -5.8%
• Year to date: -7.2%
• 1 year: -1.58%
• 5 years: 492.58%
• 10 years: 385.89%
• Sector: Healthcare
• Industry: Biotechnology

About: Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

Employees: 167

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

28% more repeat investments, than reductions

Existing positions increased: 157 | Existing positions reduced: 123

2.07% more ownership

Funds ownership: 80.89% [Q1] → 82.97% (+2.07%) [Q2]

0% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 48

2% less funds holding

Funds holding: 367 [Q1] → 358 (-9) [Q2]

8% less capital invested

Capital invested by funds: $2.39B [Q1] → $2.2B (-$190M) [Q2]

67% less funds holding in top 10

Funds holding in top 10: 6 [Q1] → 2 (-4) [Q2]

94% less call options, than puts

Call options by funds: $403K | Put options by funds: $6.2M